The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAgronomics Regulatory News (ANIC)

Share Price Information for Agronomics (ANIC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 7.75
Bid: 7.60
Ask: 7.90
Change: -0.04 (-0.51%)
Spread: 0.30 (3.947%)
Open: 7.90
High: 7.86
Low: 7.75
Prev. Close: 7.90
ANIC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

15 Apr 2013 12:34

RNS Number : 3621C
Port Erin Biopharma Investments Ltd
15 April 2013
 



Port Erin Biopharma Investments Limited

("Port Erin" or "the Company")

Changes to the Group's Board

The Board of Port Erin, the AIM listed company focused on investing in the biotechnology and biopharmaceutical sectors, announces that Nicholas Woolard has informed the Board of his decision to stand down as a Non-Executive Director of the Company with immediate effect in order to allow him to focus on other business interests. Nicholas joined the Board in May 2011 prior to the Company's listing in September 2011, and has served on its Audit and Remuneration committees since that date.

The Board further announces the appointment of Alexander Anderson Stuart Whamond as a Non-Executive Director of the Company with immediate effect. Anderson, aged 52, has over 25 years' experience in the banking and financial sector. He began his career in 1983 at White Weld Securities (part of the CSFB group) before joining Salomon Brothers International in London in 1986 and then Morgan Stanley International in 1989 where he was a principal in charge of convertible bond trading. He joined Peregrine Securities International (UK) Limited in 1993, relocating to Hong Kong in 1996 to run the equity trading businesses of Peregrine Investment Holdings Limited and becoming a director of the executive committee of the Peregrine group in 1997. In 1998, Anderson joined the Regent Pacific Group, a Hong Kong listed international emerging markets investments group, as head of corporate investments and relocated to the Isle of Man. He joined the Charlemagne Group in 2002 and was a director of AIM quoted Charlemagne Capital Limited until March 2009. He remains a non-executive director of Charlemagne Capital (IOM) Limited and is also a director of a number of listed and non-listed investment companies.

Anderson Whamond will chair both the Audit and Remuneration committees.

Jim Mellon, Chairman, commented: "Nick has made a very significant contribution to Port Erin. I would like to thank Nick on behalf of the Board for his advice and support and to wish him well for the future. I also have great pleasure in welcoming Anderson to the board, bringing as he does a wealth of experience in the investment arena."

Anderson Whamond's Directorships:-

Current Directorships

 

Atherton Electrontics Group Limited

Charlemagne Bric Plus Real Estate Company Ltd

Charlemagne Bric Property Plus Company Plc

Charlemagne Capital (IOM) Limited

Charlemagne Capital (Services) Limited

Charlemagne New Frontiers Fund

Cherrywood Consulting Limited

European Convergence Development Company Ltd

European Convergence Property Company plc

Holmeglen Limited

Interman Limited

Magna Umbrella Fund Plc

MHA Lighting Limited

OCCO Eastern European Fund

Rothesay Limited

 

Previous Directorships

 

Appleyard Investments Limited

Asian Debt Fund

Asian Fortune Enterprises Limited

Asian Opportunities Fund 1998 - I

Bald Eagle Asian Equities (non US Feeder) Fund

Bald Eagle Asian Equities Fund

Balkan Holdings (Cyprus) Limited

Burnbrae Limited

Charlemagne Capital (Barbados) Limited

Charlemagne Capital (Advisory) Limited

Charlemagne Capital (Investments) Limited

Charlemagne Capital (Caymen) Limited

Charlemagne Capital (Property) Limited

Charlemagne Capital (Investments) Limited

Charlemagne Capital Russia Fund

Charlemagne Capital Limited

Charlemagne CIS Fund Limited

Charlemagne CIS Fund (Labuan) Limited

Charlemagne Finance (Cyprus) Limited

Charlemagne Emerging Markets Fund Plc

Daeyu Regent Securities Limited

Clefex.com (IOM) Limited

EEPF (Cyprus) Limited

Diamond River International Limited

Gold Victory Holdings Limited

EIH Plc

Homeport (Cayman) Limited

Hermes Softlab d.d.

Interman Services Limited

Interman Europe plc

International Fund Arbitrage

Interman UK Limited

Ironwood Enterprises LLC

Ireton Enterprises Limited

JEM Limited

Ironwood Partnership Limited

Navrona Investments Limited

Lattice Limited

Naya Bharat Property Company Plc

Naya Bharat Property Company (Mauritius) Ltd

Novy Neft Limited

Novy Neft II Limited

Oasis Group Limited

Nowe Finanse Limited

OCCO Global Emerging Markets Fund

OCCO Asia Fund

OCCO Latin America Fund Plc

OCCO Latin America Fund

Peregrine Securities (UK) Limited

Peregrine Brokerage Limited

Port Antonio Limited

Port Antonio Developments (St. Lucia) Limited

Quayle Munro Infrastructure Company Plc

Portland Investment Company Limited

Regent European Securities (Cayman) Limited

Regent Fund Management Limited

Regent Pacific Corporate Advisory Limited

Regent Magna Europa (Cyprus) Limited

Regent Pacific Fund

Regent Pacific Energy Limited

Regent Pacific Private Equity Limited

Regent Pacific Group Limited

RPG(L) Limited

Regent Russian Bond Fund

Sleepwell Hotels (UK) Limited

Sidebottom Holdings Limited

South Asia Fund

Sleepwell Hotels Limited

Spanish Off-Plan Properties Plc

Southwise Trading Limited

SWB Investments Limited

SWA Holdings Limited

TBF(Cyprus) Limited

SWR Investments Limited

Turtle Crawl Hill Limited

Techpacific.com Limited

Ukraine Investment Fund

UAR Investments Limited

Undervalued Assets Fund - Series V Plc

Undervalued Assets Fund - Series One

Undervalued Assets Thailand Fund

Undervalued Assets Property Fund - Series Two

Undervalued Opportunities Company Limited

Undervalued Opportunities (Master) Company Ltd

WTIC Limited

Walker Telecommunications Limited

 

Ends

For further information:

For further information, please contact:

Port Erin Biopharma Investments Ltd

Libertas Capital Corporate Finance Limited

Peterhouse Capital Limited

The Company

Nomad

Broker

 

 

 

Denham Eke

+44 162 463 9396

Sandy Jamieson

+44 207 569 9650

Jon Levinson

+44 207 562 3350

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAFMGMDMKFGFZM
Date   Source Headline
26th Oct 20217:00 amRNSAgronomics EUR3 million investment in Solar Foods
26th Oct 20217:00 amRNSInSilico Medicine sale-Correction of sale proceeds
20th Oct 20218:00 amRNSAgronomics leads investment in California Cultured
12th Oct 20217:00 amRNSExercise of Warrants and Updated TVR
29th Sep 20217:00 amRNSAnnounces Sale of Oritain Shares
28th Sep 20217:00 amRNSNew Age Meats Announces US$ 25 million Series A
22nd Sep 20212:48 pmRNSPortfolio Company Update: Mosa Meat
20th Sep 20217:00 amRNSAgronomics leads VitroLabs Series A Funding
14th Sep 20217:00 amRNSPortfolio Company Update: Meatable
14th Sep 20217:00 amRNSPortfolio Company Update: BlueNalu
13th Sep 20218:00 amRNSSubscription in Formo’s US $50 million Fundraise
30th Jul 20215:34 pmRNSReplacement: Net Asset Valuation to 30 June 2021
30th Jul 202112:02 pmRNSNet Asset Value calculation to 31 June 2021
21st Jul 20211:15 pmRNSPortfolio Company Update: Shiok Meats Pte. Ltd
15th Jul 20217:00 amRNSWarrants to be traded on J P Jenkins
14th Jul 20217:00 amRNSTwo portfolio companies in XPRIZE semi-finals
13th Jul 20217:00 amRNSHalf Year Newsletter
25th Jun 20214:21 pmRNSPortfolio Company LIVEKINDLY Update
24th Jun 20215:03 pmRNSPortfolio Company Formo Update
24th Jun 20217:00 amRNSAnnounces the Sale of InSilico Medicine Inc Shares
28th May 202112:10 pmRNSResults of General Meeting, Issue of Equity & TVR
28th May 20217:00 amRNSAnnounces the Conversion of CellX SAFE
27th May 20217:00 amRNSBroker Option Results
25th May 20217:00 amRNSUpdate regarding Broker Option
20th May 20217:00 amRNSUpdate regarding Broker Option
13th May 20217:00 amRNSAnnounces Secondary Purchase of Shares in Meatable
12th May 20217:00 amRNSResult of Fundraising
11th May 202111:05 amRNSSecond Price Monitoring Extn
11th May 202111:00 amRNSPrice Monitoring Extension
11th May 202110:40 amRNSProposed Fundraise to raise £50 million
6th May 20212:30 pmRNSNew Consultancy Agreement with Shellbay
21st Apr 20218:30 amRNSInvestee Company Update: LegenDairy Foods
21st Apr 20217:00 amRNSNet Asset Value calculation to 31 March 2021
8th Apr 202110:47 amRNSInvestee Company Update: Solar Foods
30th Mar 20217:00 amRNSInvestee Company Update: LIVEKINDLY Fundraise
23rd Mar 20213:00 pmRNSMeatable Announces US$ 47 Million Financing
15th Mar 20212:06 pmRNSSecond Price Monitoring Extn
15th Mar 20212:01 pmRNSPrice Monitoring Extension
15th Mar 202111:05 amRNSSecond Price Monitoring Extn
15th Mar 202111:00 amRNSPrice Monitoring Extension
26th Feb 20217:00 amRNSPortfolio Company Update: LIVEKINDLY Collective
25th Feb 20217:00 amRNSAnnounces Further Investment in VitroLabs
18th Feb 20217:00 amRNSAnnounces Further Investment in Meatable
11th Feb 20217:00 amRNSInvestee Company Update: New Age Meats
3rd Feb 20217:00 amRNSResult of AGM
26th Jan 20217:00 amRNSHalf-year Report
20th Jan 20217:00 amRNSInvestee Company Update: BlueNalu Secures $60m
19th Jan 20213:33 pmRNSExercise of Warrants
18th Jan 20217:00 amRNSNet Asset Value calculation to 31 December 2020
16th Dec 20207:00 amRNSInvestment in SuperMeat

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.